title: Bronchoalveolar lavage fluid sample pretreatment with Sputasol(®) significantly reduces galactomannan levels.
authors.affiliation: Section of Infectious Diseases and Tropical Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria. Electronic address: juergen.prattes@medunigraz.at.
authors.forename: Juergen
authors.initials: J
authors.lastname: Prattes
authors.affiliation: Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Universitätsplatz 4, 8010 Graz, Austria.
authors.forename: Christoph
authors.initials: C
authors.lastname: Koidl
authors.affiliation: Section of Infectious Diseases and Tropical Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria; Division of Pulmonology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.
authors.forename: Susanne
authors.initials: S
authors.lastname: Eigl
authors.affiliation: Section of Infectious Diseases and Tropical Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.
authors.forename: Robert
authors.initials: R
authors.lastname: Krause
authors.affiliation: Section of Infectious Diseases and Tropical Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria; Division of Pulmonology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria; Division of Infectious Diseases, University of California San Diego (UCSD), 220 Dickinson Street, San Diego, CA 92103, United States.
authors.forename: Martin
authors.initials: M
authors.lastname: Hoenigl
mesh_terms: D001228:Aspergillosis / Q000453:epidemiology* / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male
keywords: Aspergillus; Bronchoalveolar lavage fluid; Dithiothreitol; Galactomannan; Lateral flow device test; Sputasol